WebDec 24, 2024 · Henoch-Schönlein purpura ( HSP ), a systemic illness, has been closely linked to IgA nephropathy. Other systemic diseases in which mesangial deposits of IgA are regularly observed include... WebDec 1, 2024 · However, in the STOP-IGAN study, not only glucocorticoids, but also cyclophosphamide and azathioprine were used. These agents can clearly increase the risk for serious adverse events, whereas there is no evidence that azathioprine may add benefit when combined with corticosteroids.
Controlled prospective trial of prednisolone and cytotoxics in ... - PubMed
WebApr 5, 2024 · IgA nephropathy confirmed by pathological biopsy; During the screening period, UPCR ≥ 0.5 g/g based on 24-hour urine collection at visit 1 and/or visit 2 and at visit 3; ... Treatment with immunosuppressants (cyclophosphamide, azathioprine, mycophenolate, leflunomide, tacrolimus, cyclosporine, Tripterygium wilfordii, etc.) within … WebMar 17, 2024 · IgA nephropathy (IgAN) is the most common cause of primary (idiopathic) glomerulonephritis in resource-abundant settings [ 1 ]. The treatment and prognosis of … 32鍵小鐵琴
Corticosteroids in IgA Nephropathy - American Journal of Kidney …
WebJun 1, 2000 · It is concluded that steroids and intravenous cyclophosphamide reduce proliferative lesions, reduce proteinuria and stabilize renal function in patients with crescentic IgA nephropathy. 137 PDF Sequential immunosuppressive therapy in progressive IgA nephropathy. F. Rasche, F. Keller, L. von Müller, D. Czock, P. Lepper Medicine WebA Case Report of IgA Nephropathy Coexisting with Focal Segmental Glomerulosclerosis WebFeb 1, 2003 · For advanced progressive primary IgA nephropathy (IgAN) no established therapy exists. We conducted a prospective, uncontrolled trial to evaluate the effect of … 32開本